Stay updated on AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial
Sign up to get notified when there's something new on the AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial page.

Latest updates to the AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.3 was added to the page, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer/record history area. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.3.1 is now shown on the page, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer displays the government funding notice banner that warned about potential delays and updates; core trial content and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedNew version entries have been added to the Record History section, expanding the documented changes for the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference8%

Stay in the know with updates to AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial page.